TUESDAY 2 JULY, 2019

15:00-16:00

Gathering (Exhibition Area)

16:00-17:35

Plenary 1 | How do I make the best choice for my IBD patient? Session in English

Chairs:

Yehuda Chowers, Rambam health care campus and Nitsan Maharshak, Tel Aviv Sourasky Medical Center

16:00-16:04

IBD society update: Ariella Bar-Gil Shitrit, Shaare Zedek Medical Center

16:04-16:12

Time trends in the incidence of cancer among inflammatory bowel diseases (IBD) patients in Israel – A population-based study: Matti Waterman, Rambam Health Care Campus

16:12-16:20

Mindfulness-based cognitive intervention improves work productivity and activity impairment among Crohn’s disease patients. A randomized: Doron Schwartz, Soroka Medical Center

16:20-16:50

After VARSITY trial – How should I choose the first drug for my UC patient? Silvio Danese, Humanitas University Italy

16:50-17:05

After LYRIC trial – How should I choose surgery or drugs for my CD patient? Henit Yanai, Rabin Medical Center and Oded Zmora,Yitzhak Shamir Medical Center

17:05-17:25

After CDED trial – How should I choose drugs or dietary interventions for my CD patient? Arie Levine, Wolfson Medical Center *

17:25-17:35

Discussion

17:35-17:50

Coffee Break (Exhibition Area)

17:50-18:55

Plenary 2 | JAK Inhibitors – A new class for the treatment of UC Session in English

Chairs:

Shomron Ben-Horin, Sheba Medical Center and Irit AvniBiron, Rabin medical center

17:50-18:25

JAK Inhibitors in UC – From clinical evidence to clinical practice: Geert D’Haens, University of Amsterdam, Netherlands

18:25-18:45

Growing clinical experience with JAK Inhibitors in rheumatology: Merav Lidar, Sheba Medical Center

18:45-18:55

Discussion

18:55-19:25

Cocktail Reception (Exhibition Area)

END OF DAY 1

 

WEDNESDAY 3 JULY, 2019

07:30-08:20

Light Breakfast and Gathering (Exhibition Area)

 

HALL A

HALL B

08:20-09:50

Plenary session 3 | Session in English

 

Chairs:

Iris Dotan, Rabin Medical Center and Ian M. Gralnek, Emek Medical Center

 

08:20-08:30

Opening remarks by Iris Dotan, Rabin Medical Center

 

08:30-09:00

Targets in IBD: Silvio Danese, Humanitas University Italy

 

09:00-09:25

Treating Inflammatory Bowel Diseases – A health Economics Perspective: Dan Greenberg, Ben-Gurion University of the Negev

 

09:25-09:50

Personalized screening and prevention of CRC: Revital Kariv, Tel Aviv Sourasky Medical Center

 

09:50-10:20

Coffee Break (Exhibition Area)

10:20-11:20

Session 4 | Neurogastroenterology and Motility Session in English

10:20-11:20

Session 5 | Clinical nutrition session: Personalized Nutrition – Sense and Sensibility Session in Hebrew

Chairs:

Dan Carter, Sheba Medical Center and Roy Dekel, Tel Aviv Sourasky Medical Center

Chairs:

Irit Chermesh, Rambam Medical Center and Liat Deutsch, Tel Aviv Sourasky Medical Center

10:20-10:40

Achalasia – From pneumodilation to POEM: Guy Boeckxstaens, University Hospital Leuven, Belgium

 

A Sensitive Topic – Food sensitivity assay based diet:

10:40-10:52

Targeting the Intestinal Microbiome in the Treatment of Functional Bowel Disorders – Clinical Update: Yehuda Ringel, Meir Medical Center

10:20-10:30

Yes! Worth a trial : Tal Engel, Sheba Medical Center

10:52-11:04

How to asses small intestinal failure: Josef Lyssy, Shaare Zedek Medical Center

10:30-10:40

No! waste of money: Dan M. Livovsky, Shaare Zedek Medical Center

11:04-11:20

How to manage Non achalasia esophageal outlet obstruction?

Amir Mari, EMMS Nazareth Hospital *

10:40-10:47

Discussion

 

 

10:47-11:00

Breath tests – Clinical guidelines: Eva Niv, Assuta Medical Center

 

 

11:00-11:12

Tailored nutritional treatment in IBD patients: Roni Baruch, Tel Aviv Sourasky Medical Center

 

 

11:12-11:20

High phenolic acid intake is a protective factor from colorectal adenomas among ever-smokers: Naomi Fliss Isakov, Tel Aviv Medical Center

11:20-11:30

Technical Break

11:30-12:30

Session 6 | “D.I.C.” = Diverticle.. IBD.. Celiac Session in English

11:30-12:30

Session 7 | Clear … Cut Session in Hebrew

Chairs:

Efrat Broide, Assaf Harofeh Medical Center and Ariella Bar-Gil Shitrit, Shaare Zedek Medical Center

Chairs:

Fabiana Benjaminov, Meir Medical Center and Stanislav Bezobchuk, Ziv Medical Center

11:30-11:45

Diverticular disease – Current guidelines Adi Lahat, Sheba Medical Center *

11:30-11:50

Cholangioscopy – from diagnostics to therapeutics: Idan Levy, Sheba Medical Center

11:45-12:00

Celiac disease – updates: Rachel Gingold-Belfer, Rabin Medical Center

11:50-11:58

Risk for dysplasia and carcinoma in gastric hyperplastic polyps, a large retrospective case series study: Roy Dekel, Tel Aviv Sourasky Medical Center

12:00-12:15

Mucosal healing in IBD – How far should we go? Fernando Magro, Hospital de São João, Portugal

11:58-12:06

Association of long-term proton pump inhibitors use with a diagnosis of gastric intestinal metaplasia: Yifat Snir, Rabin Medical Center

12:15-12:30

How to choose biologic therapy: Dan Turner, Shaare Zedek Medical Center

12:06-12:22

Advanced polypectomy- current capabilities and limitations: Amir Klein, Rambam Health Care Campus

 

 

12:22-12:30

Endoscopic ultrasound (EUS) guided coiling therapy of gastric varices for primary prophylaxis: Yael Milgrom, Hadassah Medical Center

12:30-13:15

Lunch Break (Exhibition Area)

13:15-14:30

Symposium A | Pathways of inflammation leading to the future Session in English

13:15-14:30

Symposium B | The medical staff as a key factor in accompanying the complex patient Session in Hebrew

Chairs:

Eran Israeli, Wolfson Medical Center and Doron Schwartz, Soroka Medical Center

Chairs:

Marius Braun, Rabin Medical Center and Ola Haj, Sheba Medical Center

13:15-13:20

Opening remarks by Eran Israeli, Wolfson Medical Center and Doron Schwartz, Soroka Medical Center

13:15-13:17

Opening remarks by chairs

13:20-13:50

Inflammation pathways in IBD: relevant cell types, commonalities and differences between CD and UC: Alexander R. Moschen, Medical University of Innsbruck, Austria

13:17-13:42

The national plan to eliminate HCV and its practical implementation: Oren Shibolet, Tel Aviv Sourasky Medical Center

13:50-14:15

How do you know the treatment works in 2020? Uri Kopylov, Sheba Medical Center

13:42-14:12

Spiritual care as complementing support for hospital nursing teams: Nirit Ulitzur, Rambam Medical Center

14:15-14:23

Residence in rural jurisdictions with reduced medical accessibility are associated with more corticosteroid treatment in Israeli patients with inflammatory bowel diseases: Oren Ledder, Shaare Zedek Medical Center

14:12-14:20

Results of implantation of sacral neuromodulation for fecal incontinence in 157 patients: a single center experience: Dan Carter, Sheba Medical Center

14:23-14:30

Three days` delay in infliximab scheduled maintenance infusions in stable IBD patients associate with significant reduction in drug trough levels: Shomron Ben-Horin, Sheba Medical Center

14:20-14:30

Discussion

14:30-14:45

Technical Break

14:45-16:00

Session 8 | Polyps – detection and surveillance Session in Hebrew

14:45-16:00

Session 9 | The Community – Where gastroenterology really happens Session in Hebrew

Chairs:

Naim Abu Freha, Soroka Medical Center and Zohar Levi, Rabin Medical Center

Chairs:

Leslie Eidelman, Clalit Health Services and Nimrod Kimchi, Bat Yamon Medical Center

14:45-14:47

Introduction by Zohar Levi, Rabin Medical Center

14:45-14:47

Introduction by Nimrod Kimchi, Bat Yamon Medical Center

14:47-14:57

FOBT – What is new? Elez Vainer, Hadassah Medical Center

14:47-15:02

Gastroenterology in geriatric patient: Matti Waterman, Rambam Health Care Campus

 

Debate: Should the IGA adopt Polyp Detection Rate as a quality measure on routine endoscopy?

15:02-15:22

The challenge of medication adherence – Present & future: Eyal Schwartzberg, Ben Gurion University of the Negev

14:57-15:07

Yes: Nathan Gluck, Tel Aviv Sourasky Medical Center

15:22-15:37

Endoscopic evaluation of iron deficiency anemia: Nimrod Kimchi, Bat Yamon Medical Center

15:07-15:17

No: Alon Basevitch, Kaplan Medical Center

15:37-15:45

Vedolizumab in elderly patients with inflammatory bowel disease: the Israeli experience: Nathaniel Aviv Cohen, Tel Aviv Medical Center

15:17-15:32

Polypectomy surveillance guidelines – Different which to adopt: Ido Laish, Sheba Medical Center

15:45-16:00

Discussion – Management of a community GI service: Leslie Eidelman, Clalit Health Services and Nimrod Kimchi, Bat Yamon Medical Center

15:32-15:47

Lynch syndrome guidelines and practice: Elizabeth Half Onn, Rambam Health Care Campus

 

 

15:47-15:55

Risk for advanced neoplasia among patients with up to two diminutive polyps with low-grade dysplasia vs. Normal colonoscopy: Zohar Levi, Rabin Medical Center

 

 

 

15:55-16:00

Discussion

 

 

16:00-16:30

Coffee Break (Exhibition Area)

16:30-17:45

Plenary Session 10 | Dangerous curves? Session in Hebrew

 

Chairs:

Adi Lahat, Sheba Medical Center and Eyal Shachar, Assaf Harofeh Medical Center

 

 

Upper GI Endoscopy – to biopsy or not?

 

16:30-16:38

Yes: Doron Boltin, Rabin Medical Center

 

16:38-16:46

No: Lior Katz, Hadassah Medical Center

 

16:46-16:50

Discussion

 

16:50-17:25

Inspiring Leadership: Adv. Rachel Tevet Wiesel, C.E.O Israel National Road Safety Authority

 

17:25-17:35

Best Abstracts Award by Doron Schwartz, Soroka Medical Center and Lior Katz, Hadassah Medical Center

 

17:35-17:45

Results announcement of the Elections to the vaad by the Election Committee: Yona Avni, Wolfson Medical Center, Fred Konikoff, Meir Medical Center and Eitan Scapa, Assaf Harofeh Medical Center

 

17:45

Farewell

END OF DAY 2

*כולל תקציר (פורמט מורחב)

 

Comtec China:
Suite 405, Universal Center Building
175 Xiang Yang Road South,
Shanghai 200031, China
Tel: +86-21-54660460
Fax: +86-21-54660450
china@comtecmed.com

Headquarters & Administration:
53 Rothschild Boulevard,
PO Box 68,
Tel Aviv, 6100001, Israel
Tel: +972-3-5666166
Fax: +972-3-5666177
info@comtecmed.com